CD33 and acute promyelocytic leukemia: In acute promyelocytic leukemia (APL) patients, peripheral ‘group 2 innate lymphoid cells’ (ILC2s) were found to be increased and hyperactivated, and in turn activated M-MDSC (CD14+CD33+) through IL-13 secretion.